Symbol
SPRO on Nasdaq
Investment type
Equity / Common Stock, par value $0.001 per share
Latest Disclosed Ownership
9.19M shares
Security Ownership
16.4%

GSK PLC ownership in Spero Therapeutics, Inc. Common Stock, par value $0.001 per share (SPRO)

2025-03-28 - GSK PLC has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.19M shares of Spero Therapeutics, Inc. Common Stock, par value $0.001 per share (SPRO). This represents 16.4% percent ownership of the company.